Opko Health, Inc.

Visual Financials
Company Name: Opko Health Inc
Ticker Symbol: OPK
CIK Number: 0000944809
WWW Address: http://www.opko.com
CEO: Dr. Phillip Frost,M.D.
No. of Employees: 674
Common Issue Type: CS
Business Description:Opko Health, Inc. is a biopharmaceutical and diagnostics company, engaged in the development and commercialization of pharmaceutical products, vaccines, diagnostic technologies, and imaging systems.

 
Industry Information: HEALTH SERVICES - Medical Appliances & Equipment [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 6.7 Down -0.4 6.7 6.72 7.11 7.25 6.98 5451289
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 3,747.9 559.4 0.00 -0.05 0.00 0.0 0.0 12.15 - 5.99
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close7.11$
PE Ratio - LTM0.0
Market Capitalisation3,747.9mil
Latest Shares Outstanding559.4mil
Earnings pS (EPS)-0.05$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate0.0%
Float334.5mil
Float as % of Shares Outstanding0.6%
Foreign Sales207mil
Domestic Sales1,014mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.40%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin49.9%
EBITDA Margin2.5%
Pre-Tax Profit Margin0.0%
Assets Turnover43.9%
Return on Assets (ROA)-0.9%
Return on Equity (ROE)-1.2%
Return on Capital Invested (ROCI)-1.0%
Current Ratio1.8
Leverage Ratio (Assets/Equity)1.3
Interest Cover-8.9
Total Debt/Equity (Gearing Ratio)0.05
LT Debt/Total Capital4.0%
Working Capital pS0.39$
Cash pS0.00$
Book-Value pS3.77$
Tangible Book-Value pS-0.04$
Cash Flow pS0.01$
Free Cash Flow pS-0.03$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.86
Price/Tangible Book Ratio0.00
Price/Cash Flow526.3
Price/Free Cash Flow-243.9
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---6.173,870,4824,172,402
4 Weeks7.255.996.2911.1104,020,15080,403,015
13 Weeks8.405.998.14-14.1-183,855,236246,735,119
26 Weeks12.035.9911.82-40.9-484,241,610530,201,372
52 Weeks12.155.998.84-20.9-433,660,723922,502,310
YTD9.555.99--23.1-314,140,047500,945,732
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
6.916.726.928.318.780.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1.131.11.33
Income0.0
Dividend0.0
Capital SpendingNA
R&D3.46NA23.59
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %257.5257.568.1
Earnings %0.00.0-100.0
EPS %0.00.00.0
EPS $-0.08-0.08-0.10
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio7.96
Current Ratio1.8
Quick Ratio (Acid Test)1.6
Liquidity Ratio (Cash)1.28
Receivables Turnover5.9
Average Collection Period61
Working Capital/Equity10.5
Working Capital pS0.39
Cash-Flow pS0.06
Free Cash-Flow pS0.02
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio3.88
Financial Leverage Ratio (Assets/Equity)0.1
Debt Ratio3.8
Total Debt/Equity (Gearing Ratio)0.05
LT Debt/Equity0.04
LT Debt/Capital Invested18.8
LT Debt/Total Liabilities78.8
Interest Cover0.0
Interest/Capital Invested0.30
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.41
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA139.44
Enterprise Value (EV)/Free Cash Flow564.10
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.86
Price/Cash Flow Ratio526.3
Price/Free Cash Flow Ratio - LTM-243.9
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-213.3
5-Y Low P/E Ratio-44.4
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.27
Current Liabilities pS0.87
Tangible Book Value pS - LTM-0.04
Book Value pS - LTM3.77
Capital Invested pS3.91
Cash pS - LTM0.00
Cash Flow pS - LTM0.01
Free Cash Flow pS - LTM-0.03
Earnings pS (EPS)-0.05
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.70
Free Cash Flow Margin 5YEAR AVG-47.13
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.-0.8
Equity Productivity0.58
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.-0.1
Capital Invested Productivity0.56
Return on Capital Invested (ROCI)-0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.1
Assets Productivity0.40
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.-0.1
Gross Profit Margin49.9
Gross Profit Margin - 5YEAR AVRG.0.5
EBITDA Margin - LTM2.5
EBIT Margin - LTM-5.4
Pre-Tax Profit Margin-0.8
Pre-Tax Profit Margin - 5YEAR AVRG.-0.8
Effective Tax Rate36.9
Effective Tax Rate - 5YEAR AVRG.11.5
EFFICIENCY RATIOS
Cash Conversion Cycle4,032,528
Revenue per Employee
Net Income per Employee
Average Collection Period4,032,528
Receivables Turnover5.9
Day's Inventory Turnover Ratio
Inventory Turnover14.1
Inventory/Sales3.9
Accounts Payble/Sales4.37
Assets/Revenue2.50
Net Working Capital Turnover5.55
Fixed Assets Turnover0.54
Total Assets Turnover0.4
Revenue per $ Cash7.24
Revenue per $ Plant9.95
Revenue per $ Common Equity0.58
Revenue per $ Capital Invested0.56
Selling, General & Adm/tive (SG&A) as % of Revenue40.2
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue9.1
R&D Expense as % of Revenue - 5YEAR AVRG.9.1

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.